Accumulation of lipid droplets in cancer cells is related to cancer progression and drug resistance.[31] Therefore, despite the challenges, targeting lipid droplet biosynthesis has been considered cancer therapy.[31, 32] Our work provides another lipid droplet‐related cancer therapeutic direction by suppressing recruitment of Numb or MDM2 to the lipid droplets. The gene discussed is MDM2; the disease is cancer.